These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24440234)
1. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent. Ojha R; Singh SK; Bhattacharyya S; Dhanda RS; Rakha A; Mandal AK; Jha V J Urol; 2014 Jun; 191(6):1889-98. PubMed ID: 24440234 [TBL] [Abstract][Full Text] [Related]
2. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux. Li JR; Cheng CL; Yang CR; Ou YC; Wu MJ; Ko JL Toxicol Lett; 2013 Jul; 220(3):267-76. PubMed ID: 23651616 [TBL] [Abstract][Full Text] [Related]
3. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. Schlütermann D; Skowron MA; Berleth N; Böhler P; Deitersen J; Stuhldreier F; Wallot-Hieke N; Wu W; Peter C; Hoffmann MJ; Niegisch G; Stork B Urol Oncol; 2018 Apr; 36(4):160.e1-160.e13. PubMed ID: 29276062 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells. Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells. Lin JF; Lin YC; Tsai TF; Chen HE; Chou KY; Hwang TI Drug Des Devel Ther; 2017; 11():1517-1533. PubMed ID: 28553083 [TBL] [Abstract][Full Text] [Related]
6. FIP-gts potentiate autophagic cell death against cisplatin-resistant urothelial cancer cells. Li JR; Cheng CL; Yang WJ; Yang CR; Ou YC; Wu MJ; Ko JL Anticancer Res; 2014 Jun; 34(6):2973-83. PubMed ID: 24922662 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells. Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644 [TBL] [Abstract][Full Text] [Related]
8. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells. Höhn A; Krüger K; Skowron MA; Bormann S; Schumacher L; Schulz WA; Hoffmann MJ; Niegisch G; Fritz G Oncotarget; 2016 Jul; 7(27):41320-41335. PubMed ID: 27191498 [TBL] [Abstract][Full Text] [Related]
9. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. Han Y; Liu Y; Gui Y; Cai Z J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726 [TBL] [Abstract][Full Text] [Related]
10. G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma. Li F; Zeng J; Gao Y; Guan Z; Ma Z; Shi Q; Du C; Jia J; Xu S; Wang X; Chang L; He D; Guo P PLoS One; 2015; 10(9):e0138390. PubMed ID: 26397365 [TBL] [Abstract][Full Text] [Related]
11. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers. Makhlin I; Zhang J; Long CJ; Devarajan K; Zhou Y; Klein-Szanto AJ; Huang M; Chernoff J; Boorjian SA BJU Int; 2011 Jul; 108(2 Pt 2):E84-90. PubMed ID: 21050361 [TBL] [Abstract][Full Text] [Related]
12. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy. Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563 [TBL] [Abstract][Full Text] [Related]
13. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Han Y; Liu Y; Nie L; Gui Y; Cai Z Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells. Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248 [TBL] [Abstract][Full Text] [Related]
16. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway. Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922 [TBL] [Abstract][Full Text] [Related]
17. The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells. Dyshlovoy SA; Madanchi R; Hauschild J; Otte K; Alsdorf WH; Schumacher U; Kalinin VI; Silchenko AS; Avilov SA; Honecker F; Stonik VA; Bokemeyer C; von Amsberg G BMC Cancer; 2017 Feb; 17(1):93. PubMed ID: 28143426 [TBL] [Abstract][Full Text] [Related]
18. Autophagy: friend or foe for progression and treatment of urothelial carcinoma. Balaji KC J Urol; 2014 Jun; 191(6):1644-5. PubMed ID: 24647081 [No Abstract] [Full Text] [Related]
19. Autophagic cell death induced by resveratrol depends on the Ca(2+)/AMPK/mTOR pathway in A549 cells. Zhang J; Chiu J; Zhang H; Qi T; Tang Q; Ma K; Lu H; Li G Biochem Pharmacol; 2013 Jul; 86(2):317-28. PubMed ID: 23680031 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y; Yoshida O; Bonavida B J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]